Don’t Let Inflation Bloat Your Drug Spending
Smart but easy tech upgrades can boost margins.
Smart but easy tech upgrades can boost margins.
While Covid-19 has had a significant impact on drug spending, IQVIA projects that its effect will moderate in coming years. IQVIA’s new report on U.S. medicines spending projects that immunology, oncology, and neurology will continue to drive the growth in drug spending.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Indeed, the growth rate is supposed to increase each year through 2020, the report says - thanks largely to drugs targeting cancer.